Companies / Italy

Chiesi Expands European Operations

March 2006 | FDI Alert

Printable version
Bookmark

Italy drugmaker Chiesi Farmaceutici has opened a subsidiary in Moscow, Russia, and formed a joint venture in the Netherlands to market its

To read the full article, please choose one of the following options:

Subcribers please log in

Related Insight Articles

More Healthcare Cost Containment To Come

Industry / Italy BMI View: The Italian pharmaceuticals and healthcare sector will be the target of further cost containment measures in 2011, as while public hospital spending has decreased, hospitals owe drugmakers millions...

June 2011

Downward Pressure On Oncology Drugs

Industry / Italy In a move to control the rising costs of healthcare and public expenditure on medicines, the Italian government is to reduce the price of numerous oncology drugs in 2011. The has been made on the basis...

July 2010

Recordati Reports Positive Revenues

Industry / Italy Pharmaceutical company Recordati's consolidated revenues for the first nine months of 2009 were US$824.1mn, a 9.4% year-on-year (y-o-y) increase, of which pharmaceutical sales increased by 10.4% y-o-y...

October 2009

State Pharmaceutical Spending Rises In H109

Industry / Italy Pharmaceutical spending by the Italian National Health Service - the Servicio Sanitario Nazionale (SSN) - increased by +0.3% year-on-year (y-o-y) in the first half of 2009, according to the Association...

October 2009

Slow Market Growth Expected In The Medium Term

Industry / Italy BMI's proprietary Drug Expenditure Forecast Model reveals that the Italian pharmaceutical market will increase in value in 2009 (in local currency terms), after declining in the previous year. During...

October 2009